XHKG6618
Market cap12bUSD
Dec 23, Last price
29.30HKD
1D
3.90%
1Q
9.53%
IPO
-73.89%
Name
JD Health International Inc
Chart & Performance
P/E
41.10
P/S
1.64
EPS
0.67
Div Yield, %
0.00%
Shrs. gr., 5y
0.23%
Rev. gr., 5y
45.64%
Revenues
53.53b
+14.54%
Net income
2.14b
+463.49%
CFO
4.60b
-22.02%
Earnings
Mar 18, 2025
Profile
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 53,529,941 14.54% | 46,736,150 52.32% | 30,682,267 58.30% | ||||
Cost of revenue | 47,544,448 | 42,261,109 | 29,048,855 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 5,985,493 | 4,475,041 | 1,633,412 | ||||
NOPBT Margin | 11.18% | 9.58% | 5.32% | ||||
Operating Taxes | 550,468 | 312,580 | 171,327 | ||||
Tax Rate | 9.20% | 6.98% | 10.49% | ||||
NOPAT | 5,435,025 | 4,162,461 | 1,462,085 | ||||
Net income | 2,141,841 463.49% | 380,105 -135.41% | (1,073,507) -93.77% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | (69,104) | (869,035) | (56,301) | ||||
BB yield | 0.06% | 0.39% | 0.03% | ||||
| Debt | |||||||
Debt current | 95,323 | 70,649 | 67,554 | ||||
Long-term debt | 334,185 | 328,171 | 334,984 | ||||
Deferred revenue | (7,819) | (8,887) | |||||
Other long-term liabilities | 7,819 | 8,887 | |||||
Net debt | (27,804,145) | (48,795,912) | (42,618,460) | ||||
| Cash flow | |||||||
Cash from operating activities | 4,604,778 | 5,905,149 | 3,430,720 | ||||
CAPEX | (69,333) | (40,160) | (502,211) | ||||
Cash from investing activities | (8,022,885) | (4,235,541) | (17,752,152) | ||||
Cash from financing activities | (117,202) | (925,449) | (163,653) | ||||
FCF | 5,398,940 | 4,171,325 | 1,316,317 | ||||
| Balance | |||||||
Cash | 41,221,260 | 47,671,966 | 41,990,080 | ||||
Long term investments | (12,987,607) | 1,522,766 | 1,030,918 | ||||
Excess cash | 25,557,156 | 46,857,924 | 41,486,885 | ||||
Stockholders' equity | (17,321,503) | (12,243,970) | (16,336,515) | ||||
Invested Capital | 66,906,521 | 56,847,756 | 56,258,849 | ||||
ROIC | 8.78% | 7.36% | 2.61% | ||||
ROCE | 12.02% | 10.03% | 4.09% | ||||
| EV | |||||||
Common stock shares outstanding | 3,163,985 | 3,144,376 | 3,094,893 | ||||
Price | 39.10 -45.20% | 71.35 20.42% | 59.25 -60.92% | ||||
Market cap | 123,711,814 -44.86% | 224,351,221 22.35% | 183,372,410 -45.23% | ||||
EV | 95,922,180 | 175,559,623 | 140,755,140 | ||||
EBITDA | 6,212,951 | 4,615,717 | 1,696,581 | ||||
EV/EBITDA | 15.44 | 38.04 | 82.96 | ||||
Interest | 9,485 | 9,099 | 5,999 | ||||
Interest/NOPBT | 0.16% | 0.20% | 0.37% | ||||